COVID-19 nasal spray vaccine offers the first line of defense against virus
15/06/2023
Promising Results in Phase I Trial of Sodium Zirconium Cyclosilicate Offer New Treatment Option for Chinese Patients
16/12/2022
× CLOSE
Promising Results in Phase I Trial of Sodium Zirconium Cyclosilicate Offer New Treatment Option for Chinese Patients
16/12/2022
New drug offers hope of ‘functional cure’ for hepatitis B patients
06/12/2022
Phase 1 Study Shows Synergistic Anti-tumour Efficacy of Combination of New Drug and Chemotherapy for HCC, Warranting Further Phase II/III Studies
11/04/2022
× CLOSE
Phase 1 Study Shows Synergistic Anti-tumour Efficacy of Combination of New Drug and Chemotherapy for HCC, Warranting Further Phase II/III Studies
11/04/2022
Phase 1 Study Proves Long-acting Formulation of Bupivacaine a Safe Means to Relieve Post-surgical Pain
29/09/2021
× CLOSE
Phase 1 Study Proves Long-acting Formulation of Bupivacaine a Safe Means to Relieve Post-surgical Pain
29/09/2021
Natural phytosterols prove to lower the low-density lipoprotein level and may reduce the risk of heart disease
24/05/2021
× CLOSE
Natural phytosterols prove to lower the low-density lipoprotein level and may reduce the risk of heart disease
24/05/2021
High cholesterol level is prevalent in Hong Kong. About half of the population have hypercholesterolemia. It is one of the major risk factor for cardiovascular diseases. Professor Bernard Cheung of HKU Department of Medicine and Dr. Ching-Lung Cheung of HKU Department of Pharmacy and Pharmacology conducted a 3-week clinical trial in 2015.
Successful Phase 1 Study on Novel FcRn Inhibitor Offers New Direction for Treatment of Autoimmune Disease
04/05/2021
× CLOSE
Successful Phase 1 Study on Novel FcRn Inhibitor Offers New Direction for Treatment of Autoimmune Disease
04/05/2021
Combined Use of Immunotherapy Drugs Improves Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma and Received FDA Approval as a Second-line Therapy for HCC
10/11/2020
× CLOSE
Combined Use of Immunotherapy Drugs Improves Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma and Received FDA Approval as a Second-line Therapy for HCC
10/11/2020
Immunotherapy Drug Proven Safe and Effective New Treatment for Asian HCC Patients
03/06/2020
× CLOSE
Immunotherapy Drug Proven Safe and Effective New Treatment for Asian HCC Patients
03/06/2020
Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies
31/07/2019
× CLOSE
Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies
31/07/2019